Cargando…
Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239592/ https://www.ncbi.nlm.nih.gov/pubmed/34222740 http://dx.doi.org/10.1002/hep4.1750 |
| _version_ | 1783715095813029888 |
|---|---|
| author | Ng, Alexander Clevewood |
| author_facet | Ng, Alexander Clevewood |
| author_sort | Ng, Alexander Clevewood |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8239592 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82395922021-06-29 Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use Ng, Alexander Clevewood Hepatol Commun Correspondence John Wiley and Sons Inc. 2021-06-22 /pmc/articles/PMC8239592/ /pubmed/34222740 http://dx.doi.org/10.1002/hep4.1750 Text en © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Ng, Alexander Clevewood Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title | Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title_full | Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title_fullStr | Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title_full_unstemmed | Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title_short | Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use |
| title_sort | letter to the editor: autoimmune hepatitis and coronavirus disease 2019: disease outcomes and tacrolimus use |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239592/ https://www.ncbi.nlm.nih.gov/pubmed/34222740 http://dx.doi.org/10.1002/hep4.1750 |
| work_keys_str_mv | AT ngalexanderclevewood lettertotheeditorautoimmunehepatitisandcoronavirusdisease2019diseaseoutcomesandtacrolimususe |